095618520	095618520	CD	B-NP	O
|	|	NN	I-NP	O
SMC	SMC	NN	I-NP	O
|	|	NN	I-NP	O
62562649	62562649	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1678003	1678003	CD	B-NP	O
|	|	CC	I-NP	O
9/25/2005	9/25/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
foot	foot	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/19/2005	10/19/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/12/2005	6/12/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
SANTIGO	SANTIGO	NN	B-NP	O
,	,	,	O	O
BRUNO	BRUNO	NN	B-NP	O
199-46-63-9	199-46-63-9	CD	I-NP	O
Boise	Boise	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/22/05	6/22/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FOHL	FOHL	NN	B-NP	O
,	,	,	O	O
BRET	BRET	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
2.5	2.5	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
NPO	NPO	NN	B-NP	B-protein
LISINOPRIL	LISINOPRIL	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
95	95	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
by	by	IN	B-PP	O
COFFER	COFFER	NN	B-NP	O
,	,	,	O	O
CLIFFORD	CLIFFORD	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
04113377	04113377	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-NP	O
SARNA	SARNA	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
rash	rash	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	B-protein
>	>	SYM	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

o	o	RB	B-ADVP	O
Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
by	by	IN	B-PP	O
BRESSER	BRESSER	NNP	B-NP	O
,	,	,	O	O
CARROLL	CARROLL	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
57188759	57188759	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
CIPROFLOXACIN	CIPROFLOXACIN	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
by	by	IN	B-PP	O
HUYETT	HUYETT	NNP	B-NP	O
,	,	,	O	O
BRANDEN	BRANDEN	NNP	B-NP	O
Q.	Q.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
26645299	26645299	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
by	by	IN	B-PP	O
URBANCIC	URBANCIC	NNP	B-NP	O
,	,	,	O	O
REGGIE	REGGIE	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NNP	I-NP	O
LINEZOLID	LINEZOLID	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/13	8/13	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
This	This	DT	B-NP	O
order	order	NN	I-NP	O
has	have	VBZ	B-VP	O
received	receive	VBN	I-VP	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
approval	approval	NN	I-NP	O
from	from	IN	B-PP	O
SLOCOMBE	SLOCOMBE	NNP	B-NP	O
,	,	,	O	O
BRENDAN	BRENDAN	NNP	B-NP	O
LAMAR	LAMAR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/22/05	6/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
vasc	vasc	NN	B-NP	O
ular	ular	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
pcp	pcp	NN	B-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
10/28/05	10/28/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
No	No	DT	B-NP	O
Known	Known	NN	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
diabetic	diabetic	JJ	B-NP	O
foot	foot	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
diabetic	diabetic	JJ	I-NP	O
foot	foot	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
edema	edema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
recurrent	recurrent	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
prolapse	prolapse	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
mitral	mitral	JJ	I-NP	B-protein
valve	valve	NN	I-NP	I-protein
prolapse	prolapse	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
uti	uti	AFX	O	B-DNA
-LRB-	-LRB-	HYPH	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atopic	atopic	JJ	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
r	r	NN	B-NP	O
foot	foot	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
foot	foot	NN	I-NP	O
xray	xray	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
YO	YO	NN	I-NP	O
female	female	JJ	B-ADJP	O
--	--	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
RLE	RLE	NN	B-NP	B-protein
ulceration/redness/pain	ulceration/redness/pain	NN	I-NP	I-protein
--	--	:	O	O
DX	DX	NN	B-NP	O
:	:	:	O	O
Diabetic	Diabetic	JJ	B-NP	O
foot	foot	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
YO	YO	NN	I-NP	O
female	female	JJ	B-ADJP	O
with	with	IN	B-PP	O
DMII	DMII	NN	B-NP	B-protein
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
AF	AF	NN	I-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
DDI	DDI	NN	B-NP	O
pacer	pacer	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
LE	LE	NN	I-NP	O
ulcerations	ulceration	NNS	I-NP	O
and	and	CC	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
amputated	amputate	VBN	B-VP	O
4/7	4/7	CD	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
considering	consider	VBG	I-VP	O
amputation	amputation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
10/25	10/25	CD	B-NP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	O
foot	foot	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
unasyn	unasyn	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
switched	switch	VBN	B-VP	O
to	to	TO	B-PP	O
Linezolid	Linezolid	NNP	B-NP	O
as	as	IN	B-PP	O
out	out	IN	B-PP	O
pt	pt	NN	B-NP	O
med	me	VBN	B-VP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
ortho	ortho	JJ	B-NP	O
and	and	CC	I-NP	O
ID	ID	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/27	11/27	CD	B-NP	O
pt	pt	NN	I-NP	O
saw	see	VBD	B-VP	O
dermatologist	dermatologist	NN	B-NP	O
and	and	CC	I-NP	O
ulcer	ulcer	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
extend	extend	VB	I-VP	O
to	to	TO	B-PP	O
bone	bone	NN	B-NP	O
and	and	CC	I-NP	O
Left	Left	NN	I-NP	O
foot	foot	NN	I-NP	O
appeared	appear	VBD	B-VP	O
cyanotic	cyanotic	JJ	B-NP	O
-	-	HYPH	I-NP	O
worrisome	worrisome	NN	I-NP	O
for	for	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
compromise	compromise	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hosp	hosp	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
STATUS	STATUS	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
97.1	97.1	CD	B-NP	O
HR	HR	NN	I-NP	O
:	:	:	O	O
75	75	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
85	85	CD	B-NP	O
/	/	SYM	I-NP	O
46	46	CD	I-NP	O
RR	RR	NN	I-NP	O
:	:	:	O	O
18	18	CD	B-NP	O
SaO2	SaO2	CD	I-NP	O
:	:	:	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
NECK	NECK	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	O
CHEST	CHEST	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
bilaterally	bilaterally	RB	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
,	,	,	O	O
S2	S2	NN	B-NP	O
3/6	3/6	CD	I-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
base	base	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
gallop	gallop	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
foot	foot	NN	I-NP	O
amputated	amputate	VBN	B-VP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
with	with	IN	B-PP	O
charcot	charcot	NN	B-NP	O
joint/hindfoot	joint/hindfoot	NN	I-NP	O
varus	varus	NN	I-NP	O
,	,	,	O	O
erthema	erthema	NN	B-NP	O
,	,	,	O	O
draining	drain	VBG	B-VP	O
ulcer	ulcer	NN	B-NP	O
fifth	fifth	JJ	I-NP	O
metatarcel	metatarcel	NN	I-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
EVENTS	EVENTS	NNS	B-NP	O
:	:	:	O	O
Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
surg	surg	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
-	-	HYPH	O	O
Left	Leave	VBN	B-NP	O
foot	foot	NN	I-NP	O
not	not	RB	B-NP	O
cyanotic	cyanotic	JJ	I-NP	O
5/17	5/17	CD	I-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
medicine	medicine	NN	B-NP	O
--	--	:	O	O
TESTS/PROCEDURES	TESTS/PROCEDURES	NN	B-NP	O
:	:	:	O	O
5/17	5/17	CD	B-NP	O
-	-	HYPH	I-NP	O
RLE	RLE	NN	I-NP	B-protein
plain	plain	JJ	I-NP	I-protein
films	film	NNS	I-NP	I-protein
-	-	HYPH	B-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
--	--	:	O	O
CONSULTS	CONSULTS	NNS	B-NP	O
:	:	:	O	O
5/17	5/17	CD	B-NP	O
ID	ID	NN	I-NP	O
5/17	5/17	CD	B-NP	O
Ortho	Ortho	NNP	I-NP	O
-	-	HYPH	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Smithhisler	Smithhisler	NNP	I-NP	O
--	--	:	O	O
PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
--	--	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

RLE	RLE	NN	B-NP	B-protein
ulcer	ulcer	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
diabetic	diabetic	JJ	I-NP	O
foot	foot	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
?	?	.	O	O

osteo	osteo	UH	B-INTJ	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
vanc	vanc	NN	B-NP	O
and	and	CC	I-NP	O
cipro	cipro	NN	I-NP	O
.	.	.	O	O

Bone	Bone	NN	B-NP	O
scan	scan	NN	I-NP	O
and	and	CC	O	O
plain	plain	JJ	B-NP	O
films	film	NNS	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
hospitalzations	hospitalzation	NNS	I-NP	O
were	be	VBD	B-VP	O
neg	neg	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
await	await	VB	I-VP	O
new	new	JJ	B-NP	O
plain	plain	JJ	I-NP	O
film	film	NN	I-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

Ortho	Ortho	NN	B-NP	O
and	and	CC	I-NP	O
ID	ID	NN	I-NP	O
were	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
recommended	recommend	VBD	B-VP	O
D/c	D/c	NN	B-NP	O
vanc	vanc	NN	I-NP	O
and	and	CC	I-NP	O
levo	levo	NN	I-NP	O
and	and	CC	O	O
starting	start	VBG	B-VP	O
linezolid	linezolid	NN	B-NP	O
.	.	.	O	O

Ortho	Ortho	NNP	B-NP	O
debrided	debride	VBD	B-VP	O
wound	wound	NN	B-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
probe	probe	VB	I-VP	O
to	to	TO	B-PP	O
bone	bone	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
2	2	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

LLE	LLE	NN	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
:	:	:	O	O
Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
vascular	vascular	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
emergent	emergent	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
required	require	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
out	out	RP	B-PRT	O
pt	pt	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
on	on	IN	B-PP	O
10/28/05	10/28/05	CD	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
deffer	deffer	VB	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
testing	testing	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Elevated	Elevated	JJ	B-NP	O
CR	CR	NN	I-NP	O
:	:	:	O	O
Baseline	Baseline	NNP	B-NP	O
Will	Will	NNP	I-NP	O
hydrate	hydrate	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

DMII	DMII	NN	B-NP	O
-	-	:	O	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
RISS	RISS	NNP	B-NP	B-protein
--	--	:	O	I-protein
5	5	CD	B-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

AF/SSS	AF/SSS	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
has	have	VBZ	B-VP	O
DDI	DDI	NN	B-NP	O
PPM	PPM	NN	I-NP	O
in	in	IN	B-PP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
--	--	:	O	I-protein
6	6	CD	B-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

CKD	CKD	NN	B-NP	B-protein
-	-	HYPH	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
DM	DM	NN	B-NP	O
-	-	HYPH	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	B-DNA
--	--	:	O	I-DNA
7	7	CD	B-NP	I-DNA
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
pls	pl	NNS	B-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
vascular	vascular	JJ	I-NP	B-protein
surgeon	surgeon	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
Dr	Dr	NN	I-NP	O
Vais	Vais	NN	I-NP	O
on	on	IN	B-PP	O
10/28/05	10/28/05	CD	B-NP	O
Pls	Pl	NNS	I-NP	B-protein
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
pls	pl	NNS	I-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
Pls	Pl	NNS	I-NP	I-protein
continue	continue	VBP	B-VP	O
daily	daily	JJ	B-NP	O
wet	wet	JJ	I-NP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
wound	wound	NN	I-NP	O
changes	change	NNS	I-NP	O
pls	pl	NNS	I-NP	O
take	take	VBP	B-VP	O
antibiotics	antibiotic	NNS	B-NP	O
as	as	IN	B-PP	O
prescribed	prescribe	VBN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Abx	Abx	NN	B-NP	B-protein
-	-	HYPH	O	O
linezolid	linezolid	NN	B-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
wks	wk	NNS	I-NP	O
INR	INR	NN	I-NP	O
check	check	NN	I-NP	O
on	on	IN	B-PP	O
10/28/05	10/28/05	CD	B-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
appointments	appointment	NNS	B-NP	O
with	with	IN	B-PP	O
ortho	ortho	JJ	B-NP	O
,	,	,	I-NP	O
vascular	vascular	JJ	I-NP	O
and	and	CC	I-NP	O
PCP	PCP	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CARMONY	CARMONY	NNP	B-NP	O
,	,	,	O	O
PORTER	PORTER	NNP	B-NP	O
L	L	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NU2	NU2	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/22/05	6/22/05	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

